China’s consumer prices fell for the third consecutive month in April, dropping by 0.1 percent year-on-year, amid sluggish spending and

The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and

Morningstar DBRS has upgraded India’s sovereign credit rating to ‘BBB’ with a stable trend, citing structural reforms, improved fiscal metrics,

Indian medical device firms anticipate significant export growth to the UK under the new FTA, potentially doubling current levels. Lower

India-Pakistan tensions: India has voiced strong concerns at the IMF’s Executive Board meeting regarding bailout packages for Pakistan, citing its

Public sector banks in India have achieved a record cumulative net profit of Rs 1.78 lakh crore for FY25, a